Last reviewed · How we verify
NCT06595550
The Effect of Whey Protein Consumption on Hypoglycemia in Adults with Type 1 Diabetes During Fasting Ramadan.
NA trial testing Whey protein in Type1 Diabetes in 44 participants. Completed in 30 November 2023.
30 August 2023
Quick facts
| Lead sponsor | King Abdullah International Medical Research Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 44 |
| Start date | 1 February 2023 |
| Primary completion | 30 August 2023 |
| Estimated completion | 30 November 2023 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Whey protein
- no Whey protein
Conditions studied
- Type1 Diabetes — all drugs for Type1 Diabetes →
- Fasting — all drugs for Fasting →
- Nutrition, Healthy — all drugs for Nutrition, Healthy →
Sponsor
King Abdullah International Medical Research Center — full company profile →
Who can join
Adults 14 to 70, any sex, with Type1 Diabetes or Fasting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cross over randomized design for adding whey protein to Suhoor meal for patients with T1DM during fasting Ramadan
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06595550
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Whey protein
Trials testing the same drug.
- NCT07528469 — The Effects of PeptiStrong and Whey on Muscle Function In Older Adults · NA · not yet recruiting
- NCT07451496 — PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS) · NA · recruiting
- NCT06825377 — Comparing High-protein Vs. Standard Protein Nutritional Support in Critically Ill Patients At Risk for Refeeding Syndrom · NA · recruiting
- NCT06955975 — The Effect of Pectin Supplementation on Geriatric With Frailty: A Randomised Placebo-Controlled Dietary Intervention Stu · NA · recruiting
- NCT06906159 — Cricket Protein Bioavailability in Younger, Middle-Aged and Older Adults · NA · completed
Other recruiting trials for Type1 Diabetes
Currently open trials in the same condition.
- NCT06408207 — CGM Academy for Youth With Type 1 Diabetes · NA · recruiting
Other King Abdullah International Medical Research Center trials
Trials by the same sponsor.
- NCT07089251 — The Perioperative Outcome of Epinephrine Infusion and Tranexamic Acid in Knee Arthroplasty Surgery · Phase 4 · recruiting
- NCT06404996 — Smart-phone Application Versus Conventional Paper for the Documentation of Voiding Dysfunction in Children · NA · not yet recruiting
- NCT06627166 — Viral Etiology of Severe Acute Respiratory InFection in CriticallY Ill Patients Registry · terminated
- NCT05421468 — Timing of Thyroxine Dose In Ramadan · NA · unknown
- NCT04862390 — Incidence of Hypoglycemia in Pregnant Ladies With or Without Gestational Diabetes Fasting Ramadan · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06595550 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Abdullah International Medical Research Center
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06595550.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing